aureus isolates with MIC 1 μg/mL or greater than 1 μg/mL, which was determined by MicroScan WalkAway showed an increasing trend.
← all excerpts
Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
2
—
—
The sentences
Line 193-195, During the study period, the proportion of MRSA isolates with vancomycin MIC � 0.5 μg/mL showed a decreasing trend; 30.8% (2010-2012), 3.3% (2013–2015), and 5.9% (2016–2018) (P for trend =0.246).